期刊名称：TRENDS IN PHARMACOLOGICAL SCIENCES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Trends in Pharmacological Sciences
Trends in Pharmacological Sciences is the leading monthly review journal in pharmacology and toxicology (Impact factor 11.394; SCI Journals Citation Reports 2001). Every issue of Trends in Pharmacological Sciences contains succinct articles on the most exciting recent developments in pharmacology and toxicology research: topics covered in the journal range from molecular to behavioural pharmacology, and from current techniques to theoretical pharmacology. Trends in Pharmacological Sciences has a prestigious Advisory Editorial Board that attest to the journals established reputation as essential reading for all pharmacologists and toxicologists, from students to professors and directors. Review articles published in Trends in Pharmacological Sciences are lively, well-illustrated and have been thoroughly peer reviewed to ensure a balanced representation of the literature. Opinion articles follow trends and innovative ideas whilst the update section is designed to highlight recent advances in a particular research field providing insight on the implications of the new developments as well as future perspectives and directions. Letters of interest to readers are also published. Careful editing of all articles ensures accessibility to the non-specialist without compromising depth or quality for the specialist. Articles are usually invited; however, if you are interested in submitting a manuscript please send a one page summary of your proposed article to the editor.
Instructions to Authors
Proposals for article should be sent to:
The Editor
Trends in Pharmacological Sciences
84 Theobalds Road
London
UK
WC1X 8RR
Fax: [44] 20 7611 4470
Phone: [44] 20 7611 4000
Email: tips@elsevier.co.uk
Editorial Board
Editor:
K. Pestell
Assistant Editor:
G. MacKenzie
Advisory Editorial Board:
S.G. Amara, Oregon University, Portland, OR, USA
H. Betz, Max Planck Institute fur Hirnforschung, Frankfurt, Germany
N.J.M Birdsall, National Institute of Medical Research, London, UK
N.G. Bowery, University of Birmingham, UK
J.N. Crawley, National Institute of Mental Health, Bethesda, MD, USA
A.C. Cuello, McGill University, Montreal, Canada
A. Dray, Astra Research Centre, Montreal, Quebec, Canada
G.I. Fishman, Mount Sinai School of Medicine, New York, NY, USA
J.R. Fozard, Sandoz, Basel, Switzerland
B.B. Fredholm, Karolinska Institute, Stockholm, Sweden
R. W. Kerwin, London, U.K.
M. Lazdunski, Universite de Nice, Valbonne, France
C.A. Maggi, Menarini Ricerche SPA, Florence, Italy
J. Meldolesi, Istituto H. San Raffaele, Milan, Italy
M. Mishina, University of Tokyo Medical & Dental University, Tokyo, Japan
W.H. Moolenaar, Netherlands Cancer Institute, Amsterdam, The Netherlands
C.P. Page, King's College, London, UK
U. Quast, University of Tubingen, Germany
R. Ruffolo Jr., SmithKline Beecham, King of Prussia, PA, USA
T.K. Sawyer, Ariad Pharmaceuticals, Cambridge, MA, USA
R.J. Summers, University of Melbourne, Melbourne, Australia
D. Wallach, Weizmann Institute of Science, Rehovot, Israel
Z.G. Wang, Institute of Basic Medical Sciences, Beijing, PRC
S.P. Watson, University of Oxford, Oxford, UK
|
